The ESMO Congress in partnership with the European Association for Cancer Research (EACR) brings together cancer researchers, clinicians and industry professionals to enable collaboration and the exchange of ideas. It is one of the most influential annual meeting for oncology professionals in Europe.
«BioEq» is a first dedicated clinical research unit for early and late stage trials. «BioEq» focuses on bioequivalence, therapeutic equivalence and phase I-IV studies.
«BioEq» will be represented by Business Development team, who will be keen to meet with pharmaceutical and biotech companies to discuss phase I-III clinical trials in Russia.
To set up a meeting please contact us at bd@«BioEq».ru
Looking forward to seeing you at ESMO 2017!